INGR

Ingredion Inc
7 filings tracked
materialsfood ingredientsMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Ingredion's first-quarter results reveal a business transitioning toward higher-value ingredient solutions, anchored by the Texture & Healthful Solutions (T&HS) segment.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The bear case for Ingredion centers on a worrying collapse in gross margins, which fell from 26% to 22% year-over-year. This compression highlights a critical inability to absorb fixed costs amidst falling volumes, particularly in the U.S.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every INGR filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company at a crossroads between operational volatility and strategic evolution. The stark contrast between the thriving T&HS segment and the struggling North American F&II business suggests that Ingredion's future valuation will depend on its ability to pivot away from traditional starches toward specialized, high-margin solutions. The immediate impact of the filing is a narrative of recovery, provided that the $20 million Argo event and $43 million Brazil closure are truly isolated incidents. Ultimately, investors must weigh the risk of continued margin compression against the potential of the PureCircle acquisition to drive long-term growth. While the balance sheet remains solvent with significant liquidity, the decline in net income to $142 million underscores the urgency for management to stabilize production and improve fixed-cost absorption. The coming quarters will determine if the current dip is a buying opportunity or a signal of a permanent shift in the company's cost structure.

Selected Quarter

Core Takeaway

Investors must decide if the 400bps gross margin drop is a temporary operational fluke or a structural decline in pricing power.

Investor Lens

The trade-off between the growth of specialized ingredients versus the volatility of the core starch business.

Watch Next

Recovery of gross margins toward 26% and the impact of the $400M-$440M CapEx spend on capacity.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.18Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%
bearishMay 8

Gross margin dropped from 26% to 22% due to lower fixed-cost absorption.

margin compression
90%
bearishMay 8

Net income attributable to Ingredion fell 28% to $142 million.

earnings miss
70%
bullishMay 8

Completed purchase of remaining shares of PureCircle to lead in sugar reduction.

acquisition
60%
bullishMay 8

Repurchased 120 thousand shares in Q1 as part of an 8 million share program.

buyback
30%

Filing History

10-QMay 8, 2026
Expand Sequence

The Q1 2026 filing presents a company at a crossroads between operational volatility and strategic evolution. The stark contrast between the thriving T&HS segment and the struggling North American F&II business suggests that Ingredion's future valuation will depend on its ability to pivot away from traditional starches toward specialized, high-margin solutions. The immediate impact of the filing is a narrative of recovery, provided that the $20 million Argo event and $43 million Brazil closure are truly isolated incidents. Ultimately, investors must weigh the risk of continued margin compression against the potential of the PureCircle acquisition to drive long-term growth. While the balance sheet remains solvent with significant liquidity, the decline in net income to $142 million underscores the urgency for management to stabilize production and improve fixed-cost absorption. The coming quarters will determine if the current dip is a buying opportunity or a signal of a permanent shift in the company's cost structure.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.